{"cursor":"25762","size":15,"audio":[],"currentlang":"en","article":"'Off-label use' is the use of pharmaceutical drugs for an unapproved indication\nor in an unapproved age group, unapproved dosage, or unapproved form of\nadministration. Both prescription drugs and over-the-\ncounter drugs (OTCs) can be used in off-label ways, although most study of off-\nlabel use centers on prescription drugs. Off-label use is generally legal unless\nit violates specific ethical guidelines or safety regulations, but it does carry\nhealth risks and differences in legal liability.\n\nA leading example of how regulatory agencies approach off-label use is provided\nby the United States Food and Drug Administration (FDA) Center for Drug\nEvaluation and Research (CDER). CDER reviews a company's New Drug Application\n(NDA) for data from clinical trials to see if the results support the drug for a\nspecific use or indication. If satisfied that the drug is safe and\neffective, the drug's manufacturer and the FDA agree on specific language\ndescribing dosage, route of administration, and other information to be included\non the drug's label. More detail is included in the drug's package insert.\n\nThe FDA approves a drug for prescription use, and continues to regulate the\npharmaceutical industry's promotional practices for that drug through the work\nof the Office of Prescription Drug Promotion (OPDP, formerly the Division for\nDrug Marketing, Advertisement and Communication (DDMAC). The FDA does\nnot have the legal authority to regulate the practice of the medicine, and the\nphysician may prescribe a drug off-label. Contrary to popular notion, it is\nlegal in the United States and in many other countries to use drugs off-label,\nincluding controlled substances such as opiates. Actiq, for example, is commonly\nprescribed off-label even though it is a Schedule II controlled substance. While\nit would be legal for a physician to independently decide to prescribe a drug\nsuch as Actiq off-label, it is illegal for the company to promote off-label uses\nto prescribers. In fact, Cephalon, the maker of Actiq, was fined for illegal\npromotion of the drug in September 2008. [http://www.usdoj.gov/archive/opa/pr/2008/September/08-civ-\n860.html ] Under the Food, Drug, and Cosmetic Act (FDCA) at U.S.C. 21 Â§Â§301-\n97, manufacturers are prohibited from directly marketing a drug for a use other\nthan the FDA approved indication. The Food and Drug Administration Modernization\nAct of 1997 created an exception to the prohibition of off-label marketing.\nManufacturers are now able to provide medical practitioners with publications on\noff-label uses of a drug, in response to an unsolicited request. 21 U.S.C.\nÂ§360aaa-6 In 2004, the federal government and whistleblower David Franklin\nreached a $430 million settlement in Franklin v. Parke-Davis to resolve claims\nthat Warner-Lambert engaged in off-label promotion of Neurontin in violation of\nthe FDCA and the False Claims Act. At the time, the settlement was one of the\nlargest recoveries against a pharmaceutical company in U.S. history, and the\nfirst off-label promotion settlement in U.S. history.\n","linknr":393,"url":"Off-label","recorded":1375692662,"links":["/w/index.php?title=Off-label_use&action=edit","/w/index.php?title=Off-label_use&action=edit","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","http://en.wikipedia.org/wiki/Off-label_use","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.visualEditor.viewPageTarget.noscript&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","/w/index.php?title=Off-label&redirect=no","#mw-navigation","#p-search","/wiki/Pharmaceutical_drug","/wiki/Indication_(medicine)","#cite_note-nejm-1","/wiki/Prescription_drug","/wiki/Over-the-counter_drug","/wiki/Legal_liability","/wiki/Regulatory_agency","/wiki/Food_and_Drug_Administration","/wiki/Center_for_Drug_Evaluation_and_Research","/wiki/New_Drug_Application","/wiki/Clinical_trials","#cite_note-2","#cite_note-3","/wiki/Physician","/wiki/Actiq","#cite_note-4","/wiki/Federal_Food,_Drug,_and_Cosmetic_Act","#cite_note-5","/wiki/David_Franklin_(scientist)","/wiki/Franklin_v._Parke-Davis","/wiki/Pfizer","/wiki/Gabapentin","/wiki/False_Claims_Act","/wiki/List_of_largest_pharmaceutical_settlements_in_the_United_States","/wiki/List_of_off-label_promotion_pharmaceutical_settlements","#cite_note-6","#Frequency_of_off-label_use","#Regulations_of_off-label_use_in_various_countries","#United_States","#United_Kingdom","#Examples_of_off-label_use_.28and_non-use.29","#Veterinary_medicine","#Research_relating_to_off-label_use","#First_Amendment_issues","#See_also","#References","#External_links","/w/index.php?title=Off-label_use&action=edit&section=1","/w/index.php?title=Off-label_use&veaction=edit&section=1","#cite_note-nejm-1","#cite_note-radley-7","#cite_note-alexander-8","#cite_note-9","#cite_note-npr.org-10","#cite_note-radley-7","/wiki/Oxytocin","/wiki/Cervidil","#cite_note-wing-11","/wiki/Bendectin","#cite_note-wing-11","/wiki/Government_Accountability_Office","/wiki/Cancer","/wiki/American_Cancer_Society","#cite_note-npr.org-10","#cite_note-cancer01-12","#cite_note-13","/wiki/Tricyclic_antidepressant","/wiki/Neuropathy","/wiki/Pain","/wiki/Antidepressant","/wiki/Clinical_depression","/wiki/Adverse_effect_(medicine)","/w/index.php?title=Off-label_use&action=edit&section=2","/w/index.php?title=Off-label_use&veaction=edit&section=2","/w/index.php?title=Off-label_use&action=edit&section=3","/w/index.php?title=Off-label_use&veaction=edit&section=3","/wiki/Physician","#cite_note-14","/wiki/Pharmaceutical","/wiki/List_of_pharmaceutical_companies","/wiki/Illness","/wiki/Medical_prescription","/wiki/Gabapentin","/wiki/Pfizer","/wiki/Seizures","/wiki/Warner-Lambert","/wiki/Continuing_medical_education","/wiki/Medical_research","#cite_note-15","#cite_note-16","/wiki/Pharmaceutical_marketing","#cite_note-17","#cite_note-18","#cite_note-19","/wiki/Pfizer","/wiki/Bextra","#cite_note-20","/w/index.php?title=Off-label_use&action=edit&section=4","/w/index.php?title=Off-label_use&veaction=edit&section=4","#cite_note-21","/w/index.php?title=Off-label_use&action=edit&section=5","/w/index.php?title=Off-label_use&veaction=edit&section=5","/wiki/Actiq","/wiki/Breakthrough_pain","#cite_note-22","/wiki/Bevacizumab","/wiki/Avastin","/wiki/Macular_degeneration","/wiki/Macular_edema","/wiki/Diabetic_retinopathy","/wiki/Central_retinal_vein_occlusion","#cite_note-23","/wiki/Buprenorphine#Antidepressant_features","#cite_note-24","#cite_note-25","/wiki/Bupropion","/wiki/SSRI","/wiki/Libido","/wiki/Carbamazepine","/wiki/Mood_stabilizer","/wiki/Bipolar_disorder","#cite_note-26","/wiki/Dexamethasone","/wiki/Betamethasone","/wiki/Premature_labor","#cite_note-wing-11","/wiki/Doxepin","/wiki/Angiodema","#cite_note-27","/wiki/Gabapentin","/wiki/Seizures","/wiki/Postherpetic_neuralgia","/wiki/Bipolar_disorder","/wiki/Essential_tremor","/wiki/Hot_flashes","/wiki/Migraine","/wiki/Neuropathic_pain","/wiki/Phantom_limb","/wiki/Restless_leg_syndrome","#cite_note-28","/wiki/Magnesium_sulfate","/wiki/Premature_labor","/wiki/Preeclampsia","#cite_note-wing-11","/wiki/Methotrexate","/wiki/Choriocarcinoma","/wiki/Ectopic_pregnancy","#cite_note-29","/wiki/SSRI","/wiki/Sertraline","/wiki/Zoloft","/wiki/Anti-depressant","/wiki/Men","/wiki/Premature_ejaculation","#cite_note-30","/wiki/Stimulants","/wiki/Amphetamine","/wiki/Adderall","/wiki/Methylphenidate","/wiki/Attention_deficit_disorder","/wiki/Atomoxetine","/wiki/Norepinephrine","/wiki/Reuptake","/wiki/Enzyme_inhibitor","/wiki/Adult_attention-deficit_disorder","/wiki/Wikipedia:Disputed_statement","/wiki/Talk:Off-label_use#Dubious","/wiki/ADHD","/wiki/Atomoxetine","/wiki/Australia","/wiki/Pharmaceutical_Benefits_Scheme","/wiki/Methylphenidate","/wiki/Dextroamphetamine","/wiki/Antidepressant","/w/index.php?title=Off-label_use&action=edit&section=6","/w/index.php?title=Off-label_use&veaction=edit&section=6","/wiki/Veterinarian","/wiki/Pharmacopeia","/wiki/Physician","/wiki/Europe","/wiki/Equine_veterinarian","/w/index.php?title=Animal_Medicinal_Drug_Use_Clarification_Act_of_1994&action=edit&redlink=1","#cite_note-31","/w/index.php?title=Off-label_use&action=edit&section=7","/w/index.php?title=Off-label_use&veaction=edit&section=7","#cite_note-32","#cite_note-33","http://www.independent.org/publications/tir/article.asp?articleID=240&issueID=21","http://web.mit.edu/evhippel/www/papers/Demonaco,%20Ali,%20Evh%20Off%20Label%20drug%20WP.pdf","http://www3.interscience.wiley.com/journal/122544649/abstract?CRETRY=1&SRETRY=0","/w/index.php?title=Off-label_use&action=edit&section=8","/w/index.php?title=Off-label_use&veaction=edit&section=8","#cite_note-34","/wiki/United_States_Court_of_Appeals_for_the_Second_Circuit","/wiki/Xyrem","/wiki/First_Amendment_to_the_United_States_Constitution","#cite_note-35","/w/index.php?title=Off-label_use&action=edit&section=9","/w/index.php?title=Off-label_use&veaction=edit&section=9","/wiki/Pharmaceutical_marketing","/wiki/Food_and_Drug_Administration_(United_States)","/w/index.php?title=Off-label_use&action=edit&section=10","/w/index.php?title=Off-label_use&veaction=edit&section=10","#cite_ref-nejm_1-0","#cite_ref-nejm_1-1","http://content.nejm.org/cgi/content/full/358/14/1427","/wiki/Digital_object_identifier","http://dx.doi.org/10.1056%2FNEJMp0802107","#cite_ref-2","http://www.fda.gov/Drugs/DevelopmentApprovalProcess/default.htm","#cite_ref-3","http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm090142.htm","#cite_ref-4","http://www.usdoj.gov/archive/opa/pr/2008/September/08-civ-860.html","/wiki/Wikipedia:Link_rot","#cite_ref-5","#cite_ref-6","http://www.justice.gov/opa/pr/2004/May/04_civ_322.htm","#cite_ref-radley_7-0","#cite_ref-radley_7-1","http://archinte.ama-assn.org/cgi/content/full/166/9/1021","/wiki/Archives_of_Internal_Medicine","/wiki/Digital_object_identifier","http://dx.doi.org/10.1001%2Farchinte.166.9.1021","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/16682577","#cite_ref-alexander_8-0","http://www.ncbi.nlm.nih.gov/pubmed/21254289","/w/index.php?title=Pharmacoepidemiology_and_Drug_Safety&action=edit&redlink=1","/wiki/Digital_object_identifier","http://dx.doi.org/10.1002%2Fpds.2082","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/21254289","#cite_ref-9","/w/index.php?title=Ambulatory_Pediatrics&action=edit&redlink=1","#cite_ref-npr.org_10-0","#cite_ref-npr.org_10-1","http://www.npr.org/templates/story/story.php?storyId=95985619","#cite_ref-wing_11-0","#cite_ref-wing_11-1","#cite_ref-wing_11-2","#cite_ref-wing_11-3","/wiki/Digital_object_identifier","http://dx.doi.org/10.1097%2FAOG.0b013e3181d53843","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/20308845","#cite_ref-cancer01_12-0","http://www.cancer.gov/clinicaltrials/learning/approval-process-for-cancer-drugs/allpages#Anchor-Wh-36735","#cite_ref-13","http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221356","/wiki/Journal_of_Medical_Internet_Research","/wiki/Digital_object_identifier","http://dx.doi.org/10.2196%2Fjmir.1643","/wiki/PubMed_Central","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3221356","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/21252034","#cite_ref-14","#cite_ref-15","http://www.annals.org/cgi/content/full/145/4/305?etoc","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/16908923","#cite_ref-16","http://www.usdoj.gov/opa/pr/2004/May/04_civ_322.htm","#cite_ref-17","http://www.annals.org/cgi/content/abstract/145/4/284","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/16908919","#cite_ref-18","http://www.cafepharma.com/quitam.asp","#cite_ref-19","http://www.mcclatchydc.com/227/story/61113.html","#cite_ref-20","http://www.usdoj.gov/opa/pr/2009/September/09-aag-900.html","/wiki/Wikipedia:Link_rot","#cite_ref-21","http://www.gmc-uk.org/guidance/current/library/prescriptions_faqs.asp#5d","#cite_ref-22","http://www.joepaduda.com/archives/000875.html","#cite_ref-23","http://www.guardian.co.uk/medicine/story/0,,1799772,00.html","#cite_ref-24","http://www.naabt.org/documents/The_Buprenorphine_effect_on_Depression.pdf","#cite_ref-25","/wiki/Digital_object_identifier","http://dx.doi.org/10.1097%2F00004714-199502000-00008","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/7714228","#cite_ref-26","http://www.leeheymd.com/charts/dep4_1.html","#cite_ref-27","http://ajp.psychiatryonline.org/cgi/reprint/140/7/957","#cite_ref-28","http://idahodur.isu.edu/leaflets/2004/GABAPENTIN%20EDU%20LEAFLET%202004.pdf","#cite_ref-29","http://drugs.nmihi.com/whd/pregnancy.html","/wiki/Wikipedia:Link_rot","#cite_ref-30","http://www.emedicine.com/med/topic643.htm#section~Medication","#cite_ref-31","http://ncseonline.org/nle/crsreports/05jun/97-905.pdf","/wiki/Wikipedia:Link_rot","#cite_ref-32","http://www.ncbi.nlm.nih.gov/pubmed/19697444","#cite_ref-33","http://journals.lww.com/lww-medicalcare/Citation/2010/04000/Clinical_Prescribing__and_Off_Label_Use__in_a.1.aspx","/wiki/Digital_object_identifier","http://dx.doi.org/10.1097%2FMLR.0b013e3181d60408","#cite_ref-34","http://www.wileyrein.com/public_document.cfm?id=29621","#cite_ref-35","http://abcnews.go.com/Health/Drugs/off-label-drug-marketing-free-speech-court-rules/story?id=17883930","/w/index.php?title=Off-label_use&action=edit&section=11","/w/index.php?title=Off-label_use&veaction=edit&section=11","http://www.thedoctorwillseeyounow.com/articles/bioethics/offlabel_11/","http://psychcentral.com/blog/archives/2008/02/17/fda-to-drug-companies-off-label-use-ok/","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","http://en.wikipedia.org/w/index.php?title=Off-label_use&oldid=565637441","/wiki/Help:Categories","/wiki/Category:Ethically_disputed_business_practices","/wiki/Category:Pharmacology","/wiki/Category:All_articles_with_dead_external_links","/wiki/Category:Articles_with_dead_external_links_from_November_2011","/wiki/Category:All_accuracy_disputes","/wiki/Category:Articles_with_disputed_statements_from_March_2008","/w/index.php?title=Special:UserLogin&returnto=Off-label+use&type=signup","/w/index.php?title=Special:UserLogin&returnto=Off-label+use","/wiki/Off-label_use","/wiki/Talk:Off-label_use","#","/wiki/Off-label_use","/w/index.php?title=Off-label_use&action=edit","/w/index.php?title=Off-label_use&veaction=edit","/w/index.php?title=Off-label_use&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","//en.wikipedia.org/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/Off-label_use","/wiki/Special:RecentChangesLinked/Off-label_use","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=Off-label_use&oldid=565637441","/w/index.php?title=Off-label_use&action=info","//www.wikidata.org/wiki/Q119697","/w/index.php?title=Special:Cite&page=Off-label_use&id=565637441","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=Off-label+use","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=Off-label+use&oldid=565637441&writer=rl","/w/index.php?title=Off-label_use&printable=yes","//de.wikipedia.org/wiki/Off-Label-Use","//es.wikipedia.org/wiki/Uso_fuera_de_indicaci%C3%B3n","//it.wikipedia.org/wiki/Off-label","//hu.wikipedia.org/wiki/Off-label_gy%C3%B3gyszeralkalmaz%C3%A1s","//nl.wikipedia.org/wiki/Niet-geregistreerd_gebruik","//no.wikipedia.org/wiki/Off-label_bruk","//pl.wikipedia.org/wiki/Pozarejestracyjne_stosowanie_lek%C3%B3w","//ru.wikipedia.org/wiki/%D0%9E%D1%84%D1%84-%D0%BB%D0%B5%D0%B9%D0%B1%D0%BB","//simple.wikipedia.org/wiki/Off-label_use","//fi.wikipedia.org/wiki/Off_label_-k%C3%A4ytt%C3%B6","#","//www.wikidata.org/wiki/Q119697#sitelinks-wikipedia","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//wikimediafoundation.org/wiki/Privacy_policy","//www.wikimediafoundation.org/","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//en.m.wikipedia.org/wiki/Off-label_use","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":["medicine","united_states","medicine","scientist"],"pdf":["http://web.mit.edu/evhippel/www/papers/Demonaco,%20Ali,%20Evh%20Off%20Label%20drug%20WP.pdf","http://www.naabt.org/documents/The_Buprenorphine_effect_on_Depression.pdf","http://idahodur.isu.edu/leaflets/2004/GABAPENTIN%20EDU%20LEAFLET%202004.pdf","http://ncseonline.org/nle/crsreports/05jun/97-905.pdf"],"categories":["Ethically disputed business practices","Pharmacology"],"headings":["Frequency of off-label use","Regulations of off-label use in various countries","Examples of off-label use (and non-use)","Veterinary medicine","Research relating to off-label use","First Amendment issues","See also","References","External links"],"image":["//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[["indication","medicine"],["david_franklin","scientist"],["adverse_effect","medicine"],["food_and_drug_administration","united_states"]],"members":["adverse_effect","food_and_drug_administration","indication","david_franklin"],"related":["Pharmaceutical_drug","Indication_(medicine)","Prescription_drug","Over-the-counter_drug","Legal_liability","Regulatory_agency","Food_and_Drug_Administration","Center_for_Drug_Evaluation_and_Research","New_Drug_Application","Clinical_trials","Physician","Actiq","Federal_Food,_Drug,_and_Cosmetic_Act","David_Franklin_(scientist)","Franklin_v._Parke-Davis","Pfizer","Gabapentin","False_Claims_Act","List_of_largest_pharmaceutical_settlements_in_the_United_States","List_of_off-label_promotion_pharmaceutical_settlements","Oxytocin","Cervidil","Bendectin","Government_Accountability_Office","Cancer","American_Cancer_Society","Tricyclic_antidepressant","Neuropathy","Pain","Antidepressant","Clinical_depression","Adverse_effect_(medicine)","Physician","Pharmaceutical","List_of_pharmaceutical_companies","Illness","Medical_prescription","Gabapentin","Pfizer","Seizures","Warner-Lambert","Continuing_medical_education","Medical_research","Pharmaceutical_marketing","Pfizer","Bextra","Actiq","Breakthrough_pain","Bevacizumab","Avastin","Macular_degeneration","Macular_edema","Diabetic_retinopathy","Central_retinal_vein_occlusion","Bupropion","SSRI","Libido","Carbamazepine","Mood_stabilizer","Bipolar_disorder","Dexamethasone","Betamethasone","Premature_labor","Doxepin","Angiodema","Gabapentin","Seizures","Postherpetic_neuralgia","Bipolar_disorder","Essential_tremor","Hot_flashes","Migraine","Neuropathic_pain","Phantom_limb","Restless_leg_syndrome","Magnesium_sulfate","Premature_labor","Preeclampsia","Methotrexate","Choriocarcinoma","Ectopic_pregnancy","SSRI","Sertraline","Zoloft","Anti-depressant","Men","Premature_ejaculation","Stimulants","Amphetamine","Adderall","Methylphenidate","Attention_deficit_disorder","Atomoxetine","Norepinephrine","Reuptake","Enzyme_inhibitor","Adult_attention-deficit_disorder","ADHD","Atomoxetine","Australia","Pharmaceutical_Benefits_Scheme","Methylphenidate","Dextroamphetamine","Antidepressant","Veterinarian","Pharmacopeia","Physician","Europe","Equine_veterinarian","Animal_Medicinal_Drug_Use_Clarification_Act_of_1994","United_States_Court_of_Appeals_for_the_Second_Circuit","Xyrem","First_Amendment_to_the_United_States_Constitution","Pharmaceutical_marketing","Food_and_Drug_Administration_(United_States)"]}